Numerai’s Usana Health Sciences USNA Stock Holding History

Numerai’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$382K	Sell	17,896 -10,830	-38%	-$204K	0.03%	612
2026 Q1	$502K	Sell	28,726 -23,602	-45%	-$468K	0.05%	520
2025 Q4	$1.03M	Buy	+52,328	New	+$1.09M	0.12%	240
2025 Q3	–	Sell	-11,430	Closed	-$349K	–	671
2025 Q2	$349K	Sell	11,430 -10,558	-48%	-$300K	0.05%	347
2025 Q1	$593K	Sell	21,988 -42,266	-66%	-$1.34M	0.11%	257
2024 Q4	$2.31M	Sell	64,254 -3,478	-5%	-$130K	0.63%	34
2024 Q3	$2.57M	Buy	+67,732	New	+$2.78M	0.68%	34

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Numerai's USNA Position: Q2 2026 in Review

Numerai reduced its Usana Health Sciences (USNA) stake by 38% in Q2 2026, selling an estimated $204K and leaving 17,896 shares worth $382K. The position accounts for 0.03% of the portfolio, ranked #612.

Numerai first reported a position in USNA in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.57M in Q3 2024. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Numerai held 17,896 shares of Usana Health Sciences worth $382K as of Q2 2026.
Numerai sold 10,830 Usana Health Sciences shares in Q2 2026, an estimated $204K.
Usana Health Sciences made up 0.03% of Numerai's portfolio in Q2 2026, its #612 holding.
Numerai first reported a position in Usana Health Sciences in Q3 2024 and has held it in 7 quarters since.
Numerai's Usana Health Sciences position peaked at $2.57M in Q3 2024.
138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.